-
EP3068240
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3068240
| EP3068240 - THEACRINE-BASED SUPPLEMENT AND METHOD OF USE THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 22.11.2019 Database last updated on 03.09.2024 | Most recent event Tooltip | 27.11.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states Ortho-Nutra LLC 242 Route 79 N Suite 3 Morganville, NJ 07751 / US | [2016/38] | Inventor(s) | 01 /
LOPEZ, Hector L. 103 Meirs Road Cream Ridge, NJ 08514 / US | 02 /
WELLS, Shawn 2504 Lincolnshire Lane Lewisville, TX 75056 / US | 03 /
ZIEGENFUSS, Tim N. 13560 Walking Stick Lane Chardon, OH 44024 / US | [2016/38] | Representative(s) | FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 / IE | [N/P] |
| Former [2016/38] | O'Connell, Maura FRKelly 27 Clyde Road Dublin D04 F838 / IE | Application number, filing date | 14862215.2 | 12.11.2014 | [2016/38] | WO2014US65289 | Priority number, date | US201361903362P | 12.11.2013 Original published format: US 201361903362 P | [2016/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015073576 | Date: | 21.05.2015 | Language: | EN | [2015/20] | Type: | A1 Application with search report | No.: | EP3068240 | Date: | 21.09.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.05.2015 takes the place of the publication of the European patent application. | [2016/38] | Search report(s) | International search report - published on: | US | 21.05.2015 | (Supplementary) European search report - dispatched on: | EP | 17.05.2017 | Classification | IPC: | A61K31/522, A23L33/10, A61K45/06, A61K36/00, A61P25/26, A61P25/24 | [2017/24] | CPC: |
A61K31/522 (EP,US);
A61K31/353 (EP,BR,US);
A61K31/57 (EP,US);
A61K36/00 (EP,BR,US);
A61K45/06 (EP,US);
A61P25/24 (EP,BR);
| C-Set: |
A61K31/353, A61K2300/00 (US,EP);
A61K31/522, A61K2300/00 (EP,US);
A61K31/57, A61K2300/00 (US,EP);
A61K36/00, A61K2300/00 (US,EP) |
| Former IPC [2016/38] | A23L33/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/38] | Title | German: | THEACRINBASIERTE ERGÄNZUNG UND VERFAHREN ZUR VERWENDUNG DAVON | [2016/38] | English: | THEACRINE-BASED SUPPLEMENT AND METHOD OF USE THEREOF | [2016/38] | French: | COMPLÉMENT À BASE DE THÉACRINE ET SON PROCÉDÉ D'UTILISATION | [2016/38] | Entry into regional phase | 28.04.2016 | National basic fee paid | 28.04.2016 | Search fee paid | 28.04.2016 | Designation fee(s) paid | 28.04.2016 | Examination fee paid | Examination procedure | 28.04.2016 | Examination requested [2016/38] | 11.12.2017 | Amendment by applicant (claims and/or description) | 26.11.2019 | Despatch of a communication from the examining division (Time limit: M06) | 07.06.2020 | Reply to a communication from the examining division | 10.12.2020 | Despatch of a communication from the examining division (Time limit: M06) | 14.09.2021 | Reply to a communication from the examining division | 08.06.2022 | Despatch of a communication from the examining division (Time limit: M04) | 18.10.2022 | Reply to a communication from the examining division | 07.02.2023 | Despatch of a communication from the examining division (Time limit: M06) | 07.09.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 01.11.2023 | Reply to a communication from the examining division | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 01.11.2023 | Request for further processing filed | 01.11.2023 | Full payment received (date of receipt of payment) Request granted | 07.11.2023 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 14.09.2021 | Request for further processing filed | 14.09.2021 | Full payment received (date of receipt of payment) Request granted | 21.09.2021 | Decision despatched | Fees paid | Renewal fee | 06.09.2016 | Renewal fee patent year 03 | 26.10.2017 | Renewal fee patent year 04 | 23.11.2018 | Renewal fee patent year 05 | 27.11.2019 | Renewal fee patent year 06 | 27.11.2020 | Renewal fee patent year 07 | 29.11.2021 | Renewal fee patent year 08 | 28.11.2022 | Renewal fee patent year 09 | 27.11.2023 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI] - ALLISON A FEDUCCIA ET AL, "Locomotor activation by theacrine, a purine alkaloid structurally similar to caffeine: Involvement of adenosine and dopamine receptors", PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, ELSEVIER, US, vol. 102, no. 2, doi:10.1016/J.PBB.2012.04.014, ISSN 0091-3057, (20120428), pages 241 - 248, (20120509), XP028496175 [X] 8,10,11 * the whole document * * abstract * * page 241, column l - column r, line 5 * * page 245, column r, paragraph 1 - page 247, column l, paragraph 3 * * page 247, column l, paragraph 3 * [I] 1-15 DOI: http://dx.doi.org/10.1016/j.pbb.2012.04.014 | International search | [A]US4833147 (MOELLER HINRICH [DE], et al); | [A]CN101289448 (UNIV SUN YAT SEN [CN]) | by applicant | - "Locomotor activation by theacrine, a purine alkaloid structurally similar to caffeine: Involvement of adenosine and dopamine receptors", ALLISON A FEDUCCIA et al., Pharmacology Biochemistry And Behavior, Elsevier, vol. 102 |